Stockholders' Equity - Schedule of stock option activity and related information (Details) - USD ($)	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Share-based Payment Arrangement [Abstract]
Options outstanding, beginning of period	0	0
Weighted average exercise price at beginning of period	$ 0	$ 0
Options outstanding, weighted average remaining contractual life (in years)	4 years 1 month 13 days	4 years 1 month 13 days
Aggregate intrinsic value, beginning balance	$ 0	$ 0
Number of stock options issued on acquisition of NCI	$ 3,349,375
Weighted average exercise price of stock options issued on acquisition of NCI in share-based payment arrangement	$ 4.06
Stock options issued on acquisition of NCI, Weighted Average Remaining Contractual Life	4 years 1 month 13 days
Stock options issued on acquisition of NCI, Aggregate Intrinsic Value	$ 3,166,100
Number of share options outstanding at end of period	3,349,375	0
Weighted average exercise price at end of period	$ 4.06	$ 0
Options outstanding, aggregate intrinsic value, ending balance	$ 3,166,100	$ 0
Number of options exercisable	1,645,625
Weighted average exercise price of options exercisable	$ 3.32
Options exercisable, weighted average remaining contractual life (in years)	4 years 14 days
Options exercisable, aggregate intrinsic value, ending balance	$ 2,765,200